These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34332864)

  • 21. [Reasons for adult immunization -- prevention of most frequent respiratory infections].
    Ludwig E
    Orv Hetil; 2014 Nov; 155(44):1743-7. PubMed ID: 25344851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA): what is the future of pneumococcal conjugate vaccination in elderly?
    van Werkhoven CH; Bonten MJ
    Future Microbiol; 2015; 10(9):1405-13. PubMed ID: 26347153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.
    Ouldali N; Levy C; Minodier P; Morin L; Biscardi S; Aurel M; Dubos F; Dommergues MA; Mezgueldi E; Levieux K; Madhi F; Hees L; Craiu I; Gras Le Guen C; Launay E; Zenkhri F; Lorrot M; Gillet Y; Béchet S; Hau I; Martinot A; Varon E; Angoulvant F; Cohen R
    JAMA Pediatr; 2019 Apr; 173(4):362-370. PubMed ID: 30715140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal pneumonia prevention among adults: is the herd effect of pneumococcal conjugate vaccination in children as good a way as the active immunization of the elderly?
    Prato R; Fortunato F; Martinelli D
    Curr Med Res Opin; 2016; 32(3):543-5. PubMed ID: 26652736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumonia in the elderly.
    Loeb M
    Curr Opin Infect Dis; 2004 Apr; 17(2):127-30. PubMed ID: 15021052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theory and strategy for Pneumococcal vaccines in the elderly.
    Namkoong H; Ishii M; Funatsu Y; Kimizuka Y; Yagi K; Asami T; Asakura T; Suzuki S; Kamo T; Fujiwara H; Tasaka S; Betsuyaku T; Hasegawa N
    Hum Vaccin Immunother; 2016; 12(2):336-43. PubMed ID: 26406267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
    Bonten MJ; Huijts SM; Bolkenbaas M; Webber C; Patterson S; Gault S; van Werkhoven CH; van Deursen AM; Sanders EA; Verheij TJ; Patton M; McDonough A; Moradoghli-Haftvani A; Smith H; Mellelieu T; Pride MW; Crowther G; Schmoele-Thoma B; Scott DA; Jansen KU; Lobatto R; Oosterman B; Visser N; Caspers E; Smorenburg A; Emini EA; Gruber WC; Grobbee DE
    N Engl J Med; 2015 Mar; 372(12):1114-25. PubMed ID: 25785969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Webber C; Patton M; Patterson S; Schmoele-Thoma B; Huijts SM; Bonten MJ;
    Vaccine; 2017 Mar; 35(9):1266-1272. PubMed ID: 28173960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.
    Isturiz RE; Hall-Murray C; McLaughlin JM; Snow V; Schmoele-Thoma B; Webber C; Thompson A; Scott DA
    Expert Rev Vaccines; 2018 Jan; 17(1):45-55. PubMed ID: 29183235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination.
    Orsi A; Ansaldi F; Trucchi C; Rosselli R; Icardi G
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.
    Angoulvant F; Levy C; Grimprel E; Varon E; Lorrot M; Biscardi S; Minodier P; Dommergues MA; Hees L; Gillet Y; Craiu I; Zenkhri F; Dubos F; Guen CG; Launay E; Martinot A; Cohen R
    Clin Infect Dis; 2014 Apr; 58(7):918-24. PubMed ID: 24532543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects.
    Vila-Córcoles A; Ochoa-Gondar O; Llor C; Hospital I; Rodríguez T; Gómez A
    Eur Respir J; 2005 Dec; 26(6):1086-91. PubMed ID: 16319340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.
    Chalmers JD; Campling J; Dicker A; Woodhead M; Madhava H
    BMC Pulm Med; 2016 May; 16(1):77. PubMed ID: 27169895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens.
    Wagenvoort GHJ; Vlaminckx BJM; van Kessel DA; Geever RCL; de Jong BAW; Grutters JC; Bos WJW; Meek B; Rijkers GT
    Vaccine; 2017 Sep; 35(37):4886-4895. PubMed ID: 28802755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia.
    van Werkhoven CH; Huijts SM
    Clin Chest Med; 2018 Dec; 39(4):733-752. PubMed ID: 30390745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining the contribution of Streptococcus pneumoniae to community-acquired pneumonia in Australia.
    Yin JK; Jayasinghe SH; Charles PG; King C; Chiu CK; Menzies RI; McIntyre PB
    Med J Aust; 2017 Nov; 207(9):396-400. PubMed ID: 29092707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
    Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
    Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort Study.
    Chiou WY; Hung SK; Lai CL; Lin HY; Su YC; Chen YC; Shen BJ; Chen LC; Tsai SJ; Lee MS; Li CY
    Medicine (Baltimore); 2015 Jul; 94(26):e1022. PubMed ID: 26131806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination.
    Blasi F; Akova M; Bonanni P; Dartois N; Sauty E; Webber C; Torres A
    Eur J Intern Med; 2017 Jan; 37():13-18. PubMed ID: 27756499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.